ClinicalTrials.gg
Drug

Ceftriaxone clinical trials

Also written Rocephin.

studies test it
79
open now
10
in phase 3
21
first study started
1998

How each study uses Ceftriaxone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Ceftriaxone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
21 Dec 1984 · ROCEPHIN · NDA 050585 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

ceftriaxone
51
Ceftriaxone Sodium
10
IV Ceftriaxone
3
Ceftriaxone (Rocephin®)
2
Ceftriaxone 2000 mg
2

Brand

Rocephin
11

Development codes

ZEFONE-1000
1

In one entry with another drug

Given together, or one or the other

Ceftriaxone sodium and Sulbactam Sodium for injection
2

Studies by the year they started

75 studies that test it; most in 2024 (8)

Studies that test Ceftriaxone, by start year
YearStudies
19981
19991
20002
20011
20021
20031
20042
20053
20063
20075
20093
20102
20113
20121
20131
20142
20156
20165
20173
20184
20194
20201
20215
20221
20233
20248
20252
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
2
Phase 2
16
Phase 3
21
Phase 4
31
No phase
13

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 9 · Other 70

Assistance Publique - Hôpitaux de Paris (3) · University of Oxford (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · University Medical Centre Ljubljana (3) · Xiangbei Welman Pharmaceutical Co., Ltd (2) · Pfizer (2) · Wyeth is now a wholly owned subsidiary of Pfizer (2) · Makerere University (2)

Often tested with

Tested in the same studies.

Metronidazole (8) · Amoxicillin (6) · Doxycycline (6) · Sulbactam (5) · Ampicillin (5) · Levofloxacin (5) · Azithromycin (4) · Gentamicins (4)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 3 phase 3 studies under way

Ceftriaxone is the comparator. A study of two new drugs counts under both.

  • 1Temocillin · Assistance Publique - Hôpitaux de Paris · next primary completion Oct 2028
Reaching primary completion within a year · 4

Studies that test Ceftriaxone.

Studies

Open first, then newest update. How each study uses Ceftriaxone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 79

See all 79 studies that test Ceftriaxone →

Given beside what is tested · 15 — Ceftriaxone is usual care or a partner of the new treatment
As the comparator · 37 — what is tested is compared with Ceftriaxone

Showing 20 of 37.

Codes

What other systems call Ceftriaxone · ClinicalTrials.gg INT007172

  • MeSH (NLM) D002443CeftriaxoneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 75J73V1629CEFTRIAXONEConfirmed FDA, NLM, Wikidata
  • RxNorm 2193Confirmed FDA, Wikidata
  • Wikidata Q421713ceftriaxoneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C62020CeftriaxoneOne source FDA
  • DrugBank DB01212One source Wikidata

Also registered as ceftriaxone sodium (UNII 023Z5BR09K · RxNorm 203172) and ceftriaxone sodium anhydrous (UNII R598PB148Q).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.